Bortezomib

CAS: 179324-69-7

Ref. TM-T2399

Produktinformation

• Name: Bortezomib
• Synonyme: Radiciol, NSC 681239, MG 341, DPBA, Brotezamide, LDP 341, B-[(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic acid, Boronic acid, B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-, Boronic acid, [(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-, Boronic acid, [3-methyl-1-[[1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-, [S-(R*,S*)]-, Bortezomib for research, Bortizomib, Brotezamide, Dpba, Ldp 341, Mg 341, Mln 341, N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-Nalpha-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide, N-[(1S)-1-(dihydroxyboranyl)-3-methylbutyl]-Nalpha-(pyrazin-2-ylcarbonyl)-D-phenylalaninamide, NSC 681239, PS 341 (pharmaceutical), Ps 314, Ps 341, Radiciol, Velcade, [(1R)-3-Methyl-1-[[(2S)-1-Oxo-3-Phenyl-2-[(Pyrazinylcarbonyl)Amino]Propyl]Amino]Butyl]-Boronic Acid
• CAS: 179324-69-7

Beschreibung

Bortezomib (LDP 341) is a 20S proteasome inhibitor (Ki=0.6 nM) that is reversible and selective. Bortezomib has antitumor activity and inhibits NF-κB, which can disrupt the cell cycle and induce apoptosis.

• Marke: Targetmol

Chemische Eigenschaften

• Molekulargewicht: 384.24
• Formel: C₁₉H₂₅BN₄O₄
• Reinheit: 100%
• Farbe/Form: Yellow Solid